Recently, China’s State Administration for Market Regulation (SAMR) officially released the first new functional claim for health foods, marking a significant step toward more scientific and standardized management of health food claims in the country. The newly approved function is “helps maintain normal platelet aggregation,” which was established based on extensive scientific research and expert review, and is intended for specific populations under the guidance of healthcare professionals or nutritionists.For years, health food functional claims in China have been limited to 27 traditional categories, such as immune support, sleep improvement, and fatigue relief. However, with rising public health awareness and advances in scientific research, these existing claims have become insufficient to meet evolving market demands. In response, SAMR has reformed its application and evaluation system for new functions, encouraging companies to conduct evidence-based research and undergo transparent, rigorous assessments.This new functional claim not only broadens the scope of health food applications but also provides clear innovation pathways for the industry. SAMR emphasized that all products claiming this new function must undergo strict registration or filing procedures, and their labeling must be truthful, scientifically sound, and non-misleading. This move aims to enhance overall product quality, protect consumer rights, and promote high-quality development of the health food sector.
近日，国家市场监督管理总局（市监总局）正式发布首个保健食品新功能目录，标志着我国保健食品功能声称管理迈入科学化、规范化新阶段。此次新增的功能为“有助于维持血小板正常聚集”，是基于大量科学研究和专家评审后确定的，适用于特定人群在医生或营养师指导下使用。长期以来，我国保健食品的功能声称主要集中在增强免疫力、改善睡眠、缓解体力疲劳等27项传统功能上。随着公众健康意识提升和科研水平进步，原有功能目录已难以满足市场需求。为此，市监总局启动新功能申报与审评机制改革，鼓励企业基于循证医学开展功能研究，并通过公开透明的程序进行评估。此次新功能的发布，不仅拓展了保健食品的适用范围，也为行业创新提供了明确方向。同时，监管部门强调，所有声称具备新功能的产品必须经过严格注册或备案，并确保标签说明真实、科学、不误导消费者。此举有助于提升行业整体质量水平，保护消费者权益，推动保健食品产业高质量发展。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/15950.html